3 months ago
ISRG
AnalystsRobbie MarcusRobbie Marcus's Stock Forecasts
AnalystsRobbie Marcus
Analyst Ranking
Top 20%
#936 out of 4868 analysts
Average Return
+4.37%
Win Rate
51%40 out of 78
Risk vs Reward
Poor
Good
Robbie Marcus's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rxsight IncRXST | +252.49% | $15.24 | $53.72 | 2023-03-06 - 2024-03-06 | Strong Buy |
Conmed CorpCNMD | +102.61% | $65.64 | $132.99 | 2020-04-22 - 2021-04-23 | Strong Buy |
Inspire Medical Systems IncINSP | +94.81% | $128.00 | $249.36 | 2020-09-21 - 2021-09-20 | Strong Buy |
Minerva Surgical IncUTRS | +89.87% | $47.00 | $4.77 | 2022-08-09 - 2023-08-09 | Strong Sell |
Cvrx IncCVRX | +84.11% | $14.79 | $27.23 | 2023-01-26 - 2024-01-26 | Strong Buy |
Robbie Marcus Analyst Color
Get additional color on Robbie Marcus's coverage of popular stocks
4 months ago
NPCE
a year ago
COO
2 years ago
SYK
2 years ago
ISRG
2 years ago
PEN
Robbie Marcus's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rxsight IncRXST | 5 | Strong Sell | $17.00 | +15.49% | Downgrades | a month ago |
Merit Medical Systems IncMMSI | 1 | Strong Buy | $120.00 | +27.05% | Initiates Coverage On | a month ago |
Cooper Companies IncCOO | 4 | Strong Buy | $110.00 | +34.69% | Maintains | 2 months ago |
Baxter International IncBAX | 8 | Hold | $36.00 | +15.50% | Maintains | 2 months ago |
Conmed CorpCNMD | 5 | Hold | $70.00 | +42.54% | Downgrades | 3 months ago |
Stryker CorpSYK | 5 | Strong Buy | $445.00 | +19.01% | Maintains | 3 months ago |
Intuitive Surgical IncISRG | 5 | Strong Buy | $675.00 | +30.86% | Maintains | 3 months ago |
Neuropace IncNPCE | 4 | Strong Buy | $14.00 | +19.76% | Maintains | 4 months ago |
Bioventus IncBVS | 3 | Hold | $13.00 | +77.84% | Upgrades | 4 months ago |
Zimmer Biomet Holdings IncZBH | 5 | Strong Buy | $128.00 | +24.21% | Upgrades | 4 months ago |
Boston Scientific CorpBSX | 6 | Strong Buy | $110.00 | +6.93% | Maintains | 4 months ago |
Insulet CorpPODD | 4 | Strong Buy | $330.00 | +30.80% | Maintains | 5 months ago |
Ceribell IncCBLL | 1 | Strong Buy | $32.00 | +98.88% | Initiates Coverage On | 6 months ago |
Atricure IncATRC | 5 | Strong Buy | $40.00 | +33.73% | Maintains | 6 months ago |
Edwards Lifesciences CorpEW | 4 | Hold | $78.00 | +3.32% | Maintains | 6 months ago |
Dexcom IncDXCM | 2 | Hold | $85.00 | +19.08% | Maintains | 6 months ago |
Ge Healthcare Technologies IncGEHC | 1 | Hold | $90.00 | +27.97% | Initiates Coverage On | 8 months ago |
Enovis CorpENOV | 2 | Hold | $50.00 | +44.55% | Maintains | 9 months ago |
Treace Medical Concepts IncTMCI | 2 | Hold | $8.00 | +12.99% | Downgrades | a year ago |
Silk Road Medical IncSILK | 3 | Hold | $21.00 | -23.61% | Maintains | a year ago |
Cvrx IncCVRX | 5 | Hold | $13.00 | +77.60% | Downgrades | a year ago |
Penumbra IncPEN | 4 | Hold | $250.00 | N/A | Downgrades | a year ago |
Zimvie IncZIMV | 3 | Hold | $16.00 | N/A | Maintains | a year ago |
Inogen IncINGN | 5 | Strong Sell | $7.00 | N/A | Maintains | a year ago |
Nevro CorpNVRO | 4 | Hold | $18.00 | N/A | Maintains | a year ago |
Inspire Medical Systems IncINSP | 4 | Strong Buy | $181.00 | N/A | Maintains | 2 years ago |
Integra Lifesciences Holdings CorpIART | 4 | Strong Sell | $43.00 | N/A | Downgrades | 2 years ago |
Bausch & Lomb CorpBLCO | 2 | Hold | $17.00 | N/A | Maintains | 2 years ago |
Abbott LaboratoriesABT | 5 | Strong Buy | $118.00 | N/A | Maintains | 3 years ago |
Minerva Surgical IncUTRS | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Medtronic PLCMDT | 2 | Hold | $105.00 | N/A | Downgrades | 3 years ago |
Irhythm Technologies IncIRTC | 1 | Strong Buy | $116.00 | N/A | Upgrades | 3 years ago |
Acutus Medical IncAFIB | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Eargo IncEAR | 2 | Strong Sell | $220.00 | N/A | Downgrades | 4 years ago |
Smiledirectclub IncSDCCQ | 2 | Strong Sell | $6.00 | N/A | Downgrades | 4 years ago |
Glaukos CorpGKOS | 1 | Hold | $55.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.